Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Harousseau
J-L
JL
René Gauducheau Cancer Center Nantes, France.
Dreyling
M
M
D002118:Calcium / Q000097:blood; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D015994:Incidence; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D009194:Myeloma Proteins / Q000032:analysis / Q000652:urine; D009367:Neoplasm Staging; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D055502:Secondary Prevention; D016896:Treatment Outcome
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009194:Myeloma Proteins; D003404:Creatinine; D002118:Calcium